TGA tightens Ozempic advice (again) as global shortage bites
The TGA is once again urging doctors against initiating patients on semaglutide, less than three months after relaxing its prescribing advice, as limited supply struggles…
Tag: Diabetes
Low carb, high reward
At age 55, Frankie has multiple health problems. Long-term mental illness has been managed with polypharmacy for many years. Clozapine therapy has contributed to weight…
PBAC plan to restrict diabetes drug prescribing ‘inconsistent with guidelines’
A proposed PBS crackdown on GLP-1 receptor agonists is inconsistent with type 2 diabetes management guidelines and will force doctors to prescribe less efficacious drugs,…
PBAC to consider semaglutide listing for weight loss
Novo Nordisk has applied for PBS funding for its subcutaneous weight loss drug Wegovy as a severe obesity treatment. The product contains the GLP-1 receptor…
Trying to lose weight? Let your loved one be your semaglutide
An overweight man with high blood pressure asked me about Ozempic (semaglutide) the other day, but said it would be difficult for him to afford.…
Patient case – emergency gastric complication of type 1 diabetes
Jamilla, 41, presents to hospital with epigastric pain, nausea and vomiting on a background of type 1 diabetes, diagnosed 11 years ago. During admission, she…
TGA approves insulin pen swap amid global shortage
The TGA will allow pharmacists to swap out certain pre-filled insulin products in response to a global shortage predicted to last until June 2024. Ryzodeg…
Semaglutide supply will remain unstable until end of 2023, warns TGA
Semaglutide could remain in short supply until the end of the year despite increased stock, the TGA has warned, amid concerns a rise in off-label…
An unusual case of diabetes
When her usual GP is on leave, 67-year-old Jen presents to a GP she has not seen previously with early cellulitis affecting her forearm, after…
‘Another burden’: RACGP rejects proposed PBS restrictions on diabetes drugs
The RACGP has rejected calls for the PBS listing for initiating GLP-1 receptor agonists to move to authority required amid concerns it will add to…
